This article originally appeared on ProPublica’s website.
The government’s new website on drug and device company ties to doctors will be incomplete and may be misleading – for now.
The government’s release today of a trove of data detailing drug and device companies’ payments to doctors has been widely hailed as a milestone for transparency. But it is also something else: a very limited window into the billions in industry spending. Before you dive in and search for a specific doctor, here are five caveats to keep in mind: Continue reading